Semaglutide appears to safeguard the heart even when patients lose little weight. In a massive international trial, heart attack and stroke risk dropped by 20% regardless of BMI. The benefit seems tied not just to slimming down but to deeper biological effects on inflammation, blood pressure, and vessel health. Researchers say this could expand who qualifies for the drug.
source https://www.sciencedaily.com/releases/2025/10/251030075125.htm
Raven personalities shape survival as human pressure grows at the Dead Sea
-
Along the stark and shimmering coastline of the Dead Sea, where desert
cliffs meet one of the world's most extreme environments, a quiet drama is
unfolding...
7 hours ago
No comments:
Post a Comment